Elevated sPDGFRβ in CSF was shown to indicate pericyte injury and BBB breakdown and predict future cognitive decline in APOE ε4 carriers but not in non-carriers independent of AD pathology (Farrall and Wardlaw, 2009; Nation et al., 2019; Montagne et al., 2020). This evidence concerns the gene APOE and Alzheimer disease.